Table 5.
FSHR polymorphisms vs endocrine parameters in patients
| FSH (mIU/mL) Mean ± std |
LH (mIU/mL) Mean ± std |
Estradiol (pg/mL) Mean ± std |
Prolactin (ng/mL) Mean ± std |
BMI (kg/m2) Mean ± std |
|
|---|---|---|---|---|---|
| −29(G→A) | |||||
| GG | 10.6 ± 10.3 | 7.1 ± 5.02 | 53.1 ± 25.1 | 14.7 ± 6.6 | 23.1 ± 2.8 |
| GA | 9.06 ± 9.2 | 6.03 ± 4.6 | 55.8 ± 23.7 | 15.6 ± 7.1 | 23.4 ± 3.9 |
| AA | 25.3 ± 4.0 | 10.1 ± 8.5 | 66.1 ± 40.6 | 13.2 ± 5.4 | 24.9 ± 2.4 |
| P value | 0.646 | 0.238 | 0.400 | 0.655 | 0.362 |
| Ala307Thr (G→A) | |||||
| GG | 7.1 ± 3.0 | 5.9 ± 3.1 | 61.0 ± 25.4 | 14.1 ± 7.2 | 23.1 ± 3.3 |
| GA | 11.7 ± 11.8 | 7.6 ± 6.4 | 52.7 ± 24.3 | 14.8 ± 6.7 | 23.3 ± 3.5 |
| AA | 11.1 ± 12.5 | 6.7 ± 5.3 | 53.9 ± 30.2 | 16.6 ± 6.0 | 23.9 ± 3.0 |
| P value | 0.389 | 0.665 | 0.333 | 0.149 | 0.701 |
| Ser680Asn (G→A) | |||||
| GG | 7.3 ± 3.5 | 5.8 ± 3.5 | 59.7 ± 23.2 | 13.6 ± 7.3 | 23.4 ± 3.0 |
| GA | 12.0 ± 11.5 | 7.5 ± 6.0 | 53.6 ± 25.1 | 15.0 ± 6.5 | 23.4 ± 3.8 |
| AA | 10.6 ± 12.3 | 6.7 ± 5.1 | 53.5 ± 30.5 | 16.36.0 ± 6.07 | 23.9 ± 3.1 |
| P value | 0.365 | 0.524 | 0.574 | 0.114 | 0.792 |
BMI body mass index, FSH follicle-stimulating hormone, LH luteinizing hormone, E2 estradiol, PRL prolactin